Indications
- Pneumocystis Jirovecii Prophylaxis (see Pneumocystis Jirovecii, [[Pneumocystis Jirovecii]])
- Prophylaxis
- Treatment
Pharmacology
- xxx
Administration
- PO
Dose Adjustment
- Hepatic
- Renal
Cautions
- Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (see Glucose-6-Phosphate Dehydrogenase Deficiency, [[Glucose-6-Phosphate Dehydrogenase Deficiency]]): dapsone should be used with great caution
- Hemoglobin M: dapsone should be used with great caution
- Methemoglobin Reductase Deficiency: dapsone should be used with great caution
Adverse Effects
Hematologic Adverse Effects
- Risk of Hemolysis in Patient with Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (see Glucose-6-Phosphate Dehydrogenase Deficiency, [[Glucose-6-Phosphate Dehydrogenase Deficiency]] and Hemolytic Anemia, [[Hemolytic Anemia]])
Pulmonary Adverse Effects
- Drug-Induced Pulmonary Eosinophilia (see Drug-Induced Pulmonary Eosinophilia, [[Drug-Induced Pulmonary Eosinophilia]])
- Drug Rash with Eosinophilia and Systemic Symptoms (DRESS Syndrome) (see Drug Rash with Eosinophilia and Systemic Symptoms, [[Drug Rash with Eosinophilia and Systemic Symptoms]])
Toxicologic Adverse Effects
- Methemoglobinemia (see Methemoglobinemia, [[Methemoglobinemia]])
References
- xxx